Axial Spondyloarthritis: Clinical Trials

645 trials for Axial Spondyloarthritis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

366 completed, 102 unknown, 63 recruiting, 38 not yet recruiting. 135 Not applicable, 100 Phase 3, 72 Phase 4, 71 Phase 2, 22 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable135Completed 67, Unknown 31, Recruiting 13, Not yet recruiting 12, Active not recruiting 8, Terminated 2, Enrolling by invitation 1, Suspended 1
Phase 3100Completed 75, Unknown 8, Terminated 6, Recruiting 4, Withdrawn 3, Active not recruiting 2, Not yet recruiting 2
Phase 472Completed 37, Unknown 14, Recruiting 6, Terminated 6, Not yet recruiting 4, Withdrawn 3, Active not recruiting 2
Phase 271Completed 32, Unknown 16, Terminated 10, Recruiting 6, Not yet recruiting 3, Active not recruiting 2, Enrolling by invitation 1, Withdrawn 1
Phase 122Completed 12, Not yet recruiting 3, Recruiting 3, Terminated 2, Enrolling by invitation 1, Unknown 1
Early Phase 14Completed 1, Terminated 1, Unknown 1, Withdrawn 1

Follow Axial Spondyloarthritis: new trials by email Literature Review of Axial Spondyloarthritis trials Research Report on Axial Spondyloarthritis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of Land- and Water-Based Exercise in Axial Spondyloarthritis
Land-Based Combined Exercise Program, Aquatic Combined Exercise Program, Home Exercise Program - Axial Spondyloarthritis and Ankylosing Spondylitis
Not applicableNot yet recruitingIzmir University of Economics502026-12-012026-09-22
A Pragmatic Trial of Interleukin-17 Inhibition Versus Janus Kinase Inhibition After Tumor Necrosis Factor-alpha Inhibitor Failure in Axial Spondyloarthritis
Secukinumab (IL-17i ), Upadacitinib (JAKi) - Axial Spondyloarthritis (AxSpA)
Phase 4Not yet recruitingThe University of Texas Health Science Center, Houston402026-11-012026-10-14
Posture Exercises in Ankylosing Spondylitis
Standard Breathing Exercise Program, Posture-Focused Exercise Program - Ankylosing Spondylitis (AS)
Not applicableNot yet recruitingMustafa Akça542026-11-012026-10-16
Pain Phenotyping of Rheumatic Diseases - An Observational Study
Bedside quantitative sensory testing - Rheumatic Diseases, Lupus Erythematosus, Systemic
Not yet recruitingNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)2252026-10-282026-10-23
Ocular Surface Changes and Meibomian Gland Dysfunction in Rheumatologic Patients
Meibomian Gland Dysfunction, Dry Eye Syndromes
Not yet recruitingAssiut University1502026-10-012026-09-09
Evaluation of Serum IL-41 Level in Patients With Ankylosing Spondylitis and Psoriatic Arthritis
IL 41 - Ankylosing Spondylitis, Psoriasis
Not yet recruitingAssiut University902026-10-012026-07-21
Postural Biofeedback and Exercise in Axial Spondyloarthritis
Standard Exercise Program, Wearable Postural Biofeedback - Axial Spondyloarthritis (AxSpA), Ankylosing Spondylitis (AS)
Not applicableNot yet recruitingIstanbul University - Cerrahpasa382026-10-012026-08-21
A Study to Assess the Safety of Subcutaneous Secukinumab for Treatment in Adult Indian Participants With Axial Spondyloarthritis (axSpA), Ankylosing Spondylitis (AS), and Non-Radiographic Axial Spondyloarthritis (nr-axSpA)
Axial Spondyloarthritis, Ankylosing Spondylitis
Not yet recruitingNovartis Pharmaceuticals602026-09-302026-07-30
Controlled Reduction of AO Spine B3 Fractures in Ankylosing Spinal Disorders Using an Inflatable Positioning Device: Technical Note and Retrospective Single-centre Case Series
Spine Fracture, Osteoporosis
Not yet recruitingDiakonie-Klinikum Stuttgart232026-09-202026-09-29
Surface Topography and Radiographic Spinal Damage in Radiographic Axial Spondyloarthritis
DIERS Formetric 4D surface topography - Axial Spondyloarthritis, Ankylosing Spondylitis
RecruitingAnkara Etlik City Hospital532026-09-192026-10-02
Vilamakitug in Spondyloarthritis Placebo-controlled Investigation for Efficacy
vilamakitug, placebo - Axial Spondyloarthritis, Ankylosing Spondylitis
Phase 2Not yet recruitingXBiotech, Inc.1502026-09-012026-05-14
RENEW Intervention for Axial Spondyloarthritis
RENEW - Axial Spondyloarthritis
Not applicableNot yet recruitingUniversity of Michigan402026-09-012026-09-23
15-Hydroxyprostaglandin Dehydrogenase in Osteoarthritis and Ankylosing Spondylitis
Osteoarthritis, Ankylosing Spondylitis
Not yet recruitingAssiut University512026-08-022026-08-07
Safety and Efficacy of Allogeneic Bone Marrow MSCs in Ankylosing Spondylitis
IV administration of CG-BM1, Placebo, CG-BM1 - Ankylosing Spondylitis
Phase 1Not yet recruitingEighth Affiliated Hospital, Sun Yat-sen University402026-07-012026-06-08
Assessment of Peripheral Neuropathy in Ankylosing Spondylitis
Nerve conduction study - Ankylosing Spondylitis, Peripheral Neuropathies
Not yet recruitingAssiut University452026-06-302026-06-12
Efficacy of the Erector Spinae Plane Block for Persistent Back Pain in Patients With Ankylosing Spondylitis
Erector spinae plane block(ESBP) - Ankylosing Spondylitis (AS), Back Pain
Not applicableRecruitingMarmara University152026-06-022026-06-08
Expression of Tim-3 on Neutrophils in Ankylosing Spondylitis
Ankylosing Spondylitis, AS
Not yet recruitingAssiut University812026-06-012026-02-03
Physical Activity Through Health Technology in Axial Spondyloarthritis
Physical activity program intervention, Usual Care Group - Axial Spondyloarthritis
Not applicableRecruitingUniversity of Washington402026-06-012026-06-11
The REFLECT Study- Flares in axSpA
Axial Spondyloarthritis (AxSpA), Axial Spondyloarthritis, Non-Radiographic
Active not recruitingRoyal United Hospitals Bath NHS Foundation Trust402026-06-012026-07-07
Impact Of Upadacitinib On The Frequency Of Acute Recurrent Anterior Uveitis In Patients With Axial Spondyloarthritis
Upadacitinib 15 MG [Rinvoq] - Axial Spondylarthritis (axSpA)
Phase 4Not yet recruitingCARE ARTHRITIS LTD.2002026-05-012026-02-06

Showing 20 of 645. Sign in to see all of them.

Narrower conditions

Spondylitis, Ankylosing (517)  ·  Arthritis, Rheumatoid (149)  ·  Arthritis, Psoriatic (125)  ·  Spondylarthritis (64)  ·  Crohn Disease (45)  ·  Arthritis (37)  ·  Colitis, Ulcerative (32)  ·  Non-Radiographic Axial Spondyloarthritis (32)  ·  Psoriasis (32)  ·  Spondylarthropathies (30)  ·  Lupus Erythematosus, Systemic (28)  ·  Motor Activity (19)  ·  Spondylitis (19)  ·  Osteoarthritis (17)

Broader conditions

Ankylosis (643)  ·  Bone Diseases (643)  ·  Musculoskeletal Diseases (640)  ·  Joint Diseases (639)  ·  Spinal Diseases (638)  ·  Spondylitis (626)  ·  Spondylarthropathies (615)  ·  Arthritis (608)  ·  Spondylarthritis (581)  ·  Skin and Connective Tissue Diseases (192)  ·  Connective Tissue Diseases (163)  ·  Immune System Diseases (162)  ·  Rheumatic Diseases (153)  ·  Autoimmune Diseases (146)

Interventions

Etanercept (50)  ·  Adalimumab (41)  ·  Infliximab (36)  ·  secukinumab (29)  ·  golimumab (21)  ·  Exercise (11)  ·  Celecoxib (10)  ·  Methotrexate (10)  ·  Certolizumab Pegol (9)  ·  upadacitinib (9)  ·  Sulfasalazine (8)  ·  bimekizumab (8)  ·  ixekizumab (8)  ·  tofacitinib (8)  ·  Anti-Inflammatory Agents, Non-Steroidal (7)

Sponsors

Novartis Pharmaceuticals (24)  ·  Pfizer (21)  ·  AbbVie (18)  ·  Charite University, Berlin, Germany (14)  ·  Merck Sharp & Dohme LLC (14)  ·  Wyeth is now a wholly owned subsidiary of Pfizer (14)  ·  AbbVie (prior sponsor, Abbott) (11)  ·  Assistance Publique - Hôpitaux de Paris (10)  ·  UCB Biopharma SRL (9)  ·  National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (8)  ·  Sun Yat-sen University (8)  ·  Abbott (7)  ·  Assiut University (6)  ·  Biocad (6)  ·  Eli Lilly and Company (6)

Countries

United States (104)  ·  Turkey (Türkiye) (97)  ·  France (93)  ·  China (83)  ·  Germany (80)  ·  United Kingdom (56)  ·  Spain (53)  ·  Netherlands (47)  ·  Czechia (46)  ·  Canada (44)  ·  Poland (43)  ·  Belgium (40)  ·  South Korea (37)  ·  Russia (35)  ·  Hungary (27)

Top investigators

Joachim Sieper, MD (6)  ·  Chunde Bao (3)  ·  Finbar O'Shea (3)  ·  Jieruo Gu, Prof (3)  ·  Joachim Sieper, Prof. (3)

Results publications

PMID 41965705, PMID 34618347, PMID 38488976, PMID 40194794, PMID 41807031, PMID 30473179, PMID 31203228, PMID 33722947, PMID 35305260, PMID 36792107, PMID 41039829, PMID 32352653, PMID 33227175, PMID 33351179, PMID 34773130, PMID 35429281, PMID 36282526, PMID 40694276, PMID 41125403, PMID 41314667, PMID 41417207, PMID 42128532, PMID 42297437, PMID 42386286, PMID 15051621, PMID 16697110, PMID 19248087, PMID 19297344, PMID 19703304, PMID 20498207, PMID 21600054, PMID 21622969, PMID 21885496, PMID 23765873, PMID 24476416, PMID 26699169, PMID 27008288, PMID 28235249, PMID 28544533, PMID 30225992, PMID 30564451, PMID 31254223, PMID 31685553, PMID 33252266, PMID 34259915, PMID 34538257, PMID 34853086, PMID 35188180, PMID 35833532, PMID 36058784

NIH funding

2015 (12), 2017 (9), 2009 (8), 2008 (4), 2016 (4), 2018 (4), 2019 (4), 2023 (4), 2014 (3), 2025 (2), 2005 (1), K08CA237619 (1), KL2TR003168 (1), P60AR020613 (1), R01AR046208 (1)